Targeted metabolomic analysis identifies metabolic reprogramming in glioma grades, suggesting new approaches for monitoring disease and personalizing therapy.
This targeted metabolomic analysis highlights distinct metabolic reprogramming across glioma grades in an Indian cohort. These findings provide insights into glioma biology in the Indian context and highlight the potential of metabolomics in tumor grading, disease monitoring, and personalized therapeutic approaches.
No takes yet. Share an insight, caveat, or question.
Mohiuddin et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: